Husová L, Husa P, Ovesná P
Interní gastroenterologická klinika Lékarské fakulty MU a FN Brno.
Vnitr Lek. 2011 Jan;57(1):61-71.
The aim of the study was to identify non-invasive investigations that would provide a sufficiently reliable prediction of the presence of varices in patients with liver cirrhosis (LC) and identification of patients in a risk of variceal bleeding.
As part of a prospective evaluation, 165 patients with alcoholic LC admitted to the Department of Internal Hepatology and Gastroenterology of the Medical School, Masaryk University in Brno between 2007-2009 were divided according to the presence of varices and variceal bleeding into three groups: I. patients with LC and varices with no variceal bleeding (N = 50), II. patients with LC with no varices and thus no variceal bleeding (N = 51), III. patients with LC and varices with confirmed variceal bleeding (N = 64). A statistical evaluation was performed of a range of haematological and biochemical parameters, spleen size and a thrombocyte, leucocyte and erythrocyte count to spleen size ratio.
Patients with varices (groups I and III) had, compared to patients with no varices (group II), a significantly larger spleen, lower thrombocyte count, lower plasma fibrinogen level, extended prothrombin time (higher INR), lower plasma GGT activity and lower erythrocyte, leucocyte and thrombocyte count to spleen size ratio. In the present cohort, statistically significant factors for the presence of variceal bleeding included lower erythrocyte count and lower level of haemoglobin, i.e. the expected effect of bleeding, lower fibrinogen serum levels, lower serum ALP activity, lower total serum protein and serum albumin, higher plasma levels of uric acid and lower leucocyte or erythrocyte count to spleen size ratio.
Using common haematological and biochemical parameters together with spleen size enables, even without endoscopic examination, highly reliable prediction of the presence of varices and identification of patients in a high risk of variceal bleeding. When these non-invasive methods are used, it is possible to eliminate the need for the invasive endoscopic examination that is frequently poorly tolerated by the patients and economically demanding.
本研究旨在确定能够对肝硬化(LC)患者静脉曲张的存在提供足够可靠预测的非侵入性检查方法,并识别有静脉曲张出血风险的患者。
作为前瞻性评估的一部分,2007年至2009年间在布尔诺马萨里克大学医学院内科肝病与胃肠病科收治的165例酒精性LC患者,根据静脉曲张和静脉曲张出血情况分为三组:I. 有静脉曲张但无静脉曲张出血的LC患者(N = 50),II. 无静脉曲张因而无静脉曲张出血的LC患者(N = 51),III. 有静脉曲张且已证实有静脉曲张出血的LC患者(N = 64)。对一系列血液学和生化参数、脾脏大小以及血小板、白细胞和红细胞计数与脾脏大小的比值进行了统计学评估。
与无静脉曲张的患者(II组)相比,有静脉曲张的患者(I组和III组)脾脏明显更大,血小板计数更低,血浆纤维蛋白原水平更低,凝血酶原时间延长(INR更高),血浆γ-谷氨酰转移酶活性更低,红细胞、白细胞和血小板计数与脾脏大小的比值更低。在本队列中,静脉曲张出血存在的统计学显著因素包括红细胞计数降低和血红蛋白水平降低,即出血的预期影响,纤维蛋白原血清水平降低,血清碱性磷酸酶活性降低,血清总蛋白和血清白蛋白降低,血浆尿酸水平升高,白细胞或红细胞计数与脾脏大小的比值降低。
即使不进行内镜检查,使用常见的血液学和生化参数以及脾脏大小,也能够对静脉曲张的存在进行高度可靠的预测,并识别出有高静脉曲张出血风险的患者。使用这些非侵入性方法,可以消除患者耐受性通常较差且经济成本较高的侵入性内镜检查的必要性。